Maison Solutions MSS 深 沪
等待开盘 09-13 09:30:00 美东时间
0.8832
-0.227
-20.43%
华盛通- 最 高1.1193
- 今 开1.11
- 成交量 33.05万股
- 最 低 0.8765
- 昨 收 1.11
- 总市值 1739.06万
- 52周最高 2.08
- 市盈率 静 13.40
- 换手率 1.68%
- 52周最低 0.6801
- 委 比 66.25%
- 总股本 1969.05万
- 历史最高 22.97
- 量 比 0.28
- 振 幅 21.87%
- 历史最低 0.6005
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Maison Solutions Inc. Secures $5.25 Million Loan
Maison Solutions Inc. Class A ( ($MSS) ) just unveiled an announcement. On Sept...
09-11 03:28
Agenus Says Investigational Combination BOT/BAL Now Available To Eligible Patients With Refractory MSS mCRC Under France's Compassionate Access Framework
Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable
09-09 19:45
Maison Solutions Inc. Updates CEO and CFO Salaries
Maison Solutions Inc. Class A ( ($MSS) ) has shared an update. On August 28, 20...
08-29 04:52
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in th...
08-28 22:44
中金：维持康方生物跑赢行业评级 上调目标价至225.00港元
中金发布研报称，维持康方生物（09926）2025年和2026年盈利预测不变。维持跑赢行业评级，该行上调AK112临床成功率并将SummitAK112再授权...
08-27 10:26
Maison Solutions reports FY results
Maison Solutions press release (NASDAQ:MSS): Total net revenues for fiscal year 2025 increased 114.0% to $124.2 million compared to $58.0 million last fiscal year. Net income attributable to Maison So...
08-15 01:30
